WBD shares trade at 12% discount ahead of April 23 Paramount merger vote
Mergers & Acquisitions

WBD shares trade at 12% discount ahead of April 23 Paramount merger vote

Shareholders set to vote on $31 per cash share acquisition as regulatory scrutiny and debt concerns weigh on deal prospects

Warner Bros Discovery shares are trading at a significant discount to Paramount Global's proposed acquisition price, with investors bracing for regulatory hurdles that could derail the $110 billion media mega-merger.

WBD stock closed at $27.22 on Wednesday, roughly 12% below the all-cash offer of $31 per share. The discount reflects mounting concerns over antitrust scrutiny and the combined company's debt burden, even as shareholders prepare to vote on the transaction during a special meeting on April 23.

The deal, announced February 27, would create one of the world's largest media and entertainment companies, valued at $81 billion in equity and $110 billion on an enterprise basis. Paramount is acquiring all outstanding WBD shares in cash, positioning the combined entity to challenge streaming giants Netflix and Disney through the integration of Paramount+ and HBO Max.

But the proposed consolidation faces formidable obstacles. The U.S. Department of Justice has issued a second request for information, indicating a thorough antitrust review, while California Attorney General Rob Bonta has confirmed an ongoing state-level investigation and is considering an antitrust lawsuit. The Los Angeles County Board of Supervisors has also requested an economic impact study and urged county attorneys to formally address antitrust concerns with federal regulators.

Credit rating agencies have sounded alarms over the financing structure. Fitch Ratings downgraded Paramount to junk status on March 3, lowering its issuer rating from BBB- to BB+ and warning that the combined company's projected debt load exceeding $90 billion would far exceed acceptable leverage thresholds. The agency cited "significantly increased leverage" from the debt-financed acquisition alongside "ongoing free cash flow headwinds from significant transformation costs."

The deal includes substantial protections for WBD shareholders. Paramount has agreed to a $7 billion regulatory termination fee payable to WBD if antitrust authorities block the transaction. Additionally, if the merger has not closed by September 30, 2026, WBD shareholders are entitled to a quarterly ticking fee of $0.25 per share, providing compensation for deal delay.

Analysts project the transaction could generate more than $6 billion in synergies through technology integration, corporate-wide efficiencies, and streamlined operations. However, these savings may come at the cost of significant workforce reductions, raising additional concerns among labor advocates and local officials.

A class action law firm announced an investigation into the sale on March 23, examining whether WBD's board fulfilled its fiduciary duties in accepting Paramount's offer. The investigation adds another layer of uncertainty ahead of the shareholder vote.

The merger timeline has extended into late 2026, with regulatory approvals expected to take several months. The Hart-Scott-Rodino waiting period expired in early March, clearing an initial U.S. antitrust hurdle, but the comprehensive federal and state reviews remain ongoing.

Warner Bros Discovery CEO David Zaslav has publicly acknowledged that regulatory approval is not guaranteed, noting the $7 billion termination fee structure reflects the deal risk. Paramount's leadership has maintained confidence that the combination will withstand scrutiny, arguing that the merger would enhance consumer choice rather than diminish competition in the streaming marketplace.

With the April 23 vote approaching, institutional investors face a decision: accept the premium to current trading levels and bet on regulatory approval, or reject the deal and await potentially higher offers from other suitors. The trading spread suggests market participants are assigning roughly a one-in-four probability that the deal collapses under regulatory pressure—a wager that will be tested in the coming months.